Visualizing Personalized Cancer Risk Prediction

نویسنده

  • Maulik R. Kamdar
چکیده

Cancer, as we now know, is a genetic disease. This knowledge entails that to enable evidence-based personalized diagnosis for any patient, the location of where the tumor occurs (e.g. brain, liver, etc.) is less relevant than the underlying genetic signature that the cancer cells express (i.e. whether genes are silenced, amplified or mutated). With the advent of high-throughput gene sequencing technologies, it has been possible to sequence the entire human genome of disease-diagnosed or normal patients. As a consequence, large repositories of genomic datasets are now available for data analysis, and identifying the underlying patterns could aid in the diagnosis, prognosis and treatment on a personalized basis. The Cancer Genome Atlas (TCGA) publishes data pertaining to the molecular information (Exon (mRNA) expression, DNA Methylation, Single Nucleotide Polymorphisms (SNP), Copy Number Variations (CNV) etc.) and clinical attributes of around 9000 patients tested across different cancer typologies. Data from TCGA is of high value for oncologists as it enables matching the genomic evidence found in their own patients with those enrolled in the TCGA project. TCGA data has been widely used for hypothesis-driven translational research as all of its data results are from direct experimental evidence. Previous research has been carried out for the discovery of new tumor bio-markers (genes or single nucleotides) using unsupervised learning algorithms, and classification of patient samples using supervised learning methods. However most of these analyses use TCGA Exon Expression or SNP datasets. It has been shown recently that DNA methylation signatures are robust bio-markers, vastly more stable than mRNA or proteins, and hence will extend our ability to classify cancer and predict outcome beyond what is currently possible. This could lead the development of new approaches for diagnosis and prognosis of different kinds of cancer [1]. However, class prediction based on these patterns is an under-determined problem, due to the extreme high dimensionality of the data compared to the usually small number of available samples. Hence, a reduction of the data dimensionality, through a combination of several feature selection methods, is a necessary pre-processing step for classification performance.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

CROSSING THE WAY OF PRECISION MEDICINE APPROACH IN PERSONALIZED MEDICINE RESEARCH CENTER: A SYSTEMATIC REVIEW

Background: Precision medicine is a new approach in the field of medical sciences that utilizes the genetic characteristics of each patient along with clinical information to guide decisions related to diagnosis and early treatment of diseases. The Personalized Medicine Research Center, as the only center approved by the Ministry of Health, is working on precision medicine context and producing...

متن کامل

Personalized dynamic prediction of death according to tumour progression and high-dimensional genetic factors: Meta-analysis with a joint model.

Developing a personalized risk prediction model of death is fundamental for improving patient care and touches on the realm of personalized medicine. The increasing availability of genomic information and large-scale meta-analytic data sets for clinicians has motivated the extension of traditional survival prediction based on the Cox proportional hazards model. The aim of our paper is to develo...

متن کامل

Building personalized treatment plans for early-stage colorectal cancer patients

We developed a series of models to predict the likelihood of recurrence and the response to chemotherapy for the personalized treatment of stage I and II colorectal cancer patients. A recurrence prediction model was developed from 235 stage I/II patients. The model successfully distinguished between high-risk and low-risk groups, with a hazard ratio of recurrence of 4.66 (p < 0.0001). More impo...

متن کامل

Personalized Cancer Care Conference

The Oslo University Hospital (Norway), the K.G. Jebsen Centre for Breast Cancer Research (Norway), The Radiumhospital Foundation (Norway) and the Fritz-Bender-Foundation (Germany) designed under the conference chairmen (E. Mihich, K.S. Zänker, A.L. Borresen-Dale) and advisory committee (A. Borg, Z. Szallasi, O. Kallioniemi, H.P. Huber) a program at the cutting edge of "PERSONALIZED CANCER CARE:...

متن کامل

Personalized Immunology in Cancer: Paving the Way Towards a Better Quality of Life

Conventionally, in specific diseases, patients receive similar therapies; relying on a "one size fits all" approach. The discovery of P5 (Predictive, Preventive, Personalized, Participatory, and psycho-cognitive) improves personalized diagnosis, treatment, and prognosis. Considering the high prevalence, mortality rate, and complexity of cancers, there is a critical necessity to choose specific ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2014